Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Phase I Open Label Trial to Assess Safety of BIBW 2992 (Afatinib) in Combination With Herceptin® in Patients With HER2-positive Advanced Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 201335 as Softgel Capsule in Naive Hepatitis C Virus (HCV) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
- Status
- COMPLETED
- Phase
- N/A
PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients
- Status
- COMPLETED
- Phase
- PHASE1
An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
(Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis
- Status
- COMPLETED
- Phase
- PHASE2
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Actuation Indicator Trial in Patients With COPD
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
The Canadian Cohort Obstructive Lung Disease
- Status
- UNKNOWN
- Phase
- N/A
Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid
- Status
- COMPLETED
- Phase
- PHASE3
Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study
- Status
- COMPLETED
- Phase
- N/A
Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2
- Status
- COMPLETED
- Phase
- PHASE1
The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
- Status
- TERMINATED
- Phase
- NA
4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients
- Status
- COMPLETED
- Phase
- PHASE1